Business Description
Modalis Therapeutics Corp
ISIN : JP3922600006
Share Class Description:
TSE:4883: Ordinary SharesCompare
Compare
Traded in other countries / regions
4883.Japan IPO Date
2020-08-03Description
Modalis Therapeutics Corp is a drug development company. It is engaged in research and development of Gene Therapy using core platform technology, non-editing CRISPR technology (CRISPR-GNDM). The company's products in pipeline are MDL-201, MDL-202, MDL-204, MDL-205, MDL-206, MDL-101, and MDL-102.
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 3.9 | |||||
Equity-to-Asset | 0.65 | |||||
Debt-to-Equity | 0.36 | |||||
Debt-to-EBITDA | -0.16 | |||||
Piotroski F-Score | 1/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -74.5 | |||||
3-Year EPS without NRI Growth Rate | -64.9 | |||||
3-Year FCF Growth Rate | -17.4 | |||||
3-Year Book Growth Rate | -42.5 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 55.52 | |||||
9-Day RSI | 51.08 | |||||
14-Day RSI | 47.73 | |||||
6-1 Month Momentum % | -40 | |||||
12-1 Month Momentum % | -75.7 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 9.79 | |||||
Quick Ratio | 9.75 | |||||
Cash Ratio | 9.32 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -5.4 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -121.24 | |||||
ROA % | -100.59 | |||||
ROIC % | -940.2 | |||||
ROC (Joel Greenblatt) % | -4885.22 | |||||
ROCE % | -109.78 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 2.37 | |||||
Price-to-Tangible-Book | 2.37 | |||||
EV-to-EBIT | -0.58 | |||||
EV-to-EBITDA | -0.58 | |||||
EV-to-FCF | -0.59 | |||||
Price-to-Net-Current-Asset-Value | 2.55 | |||||
Price-to-Net-Cash | 2.76 | |||||
Earnings Yield (Greenblatt) % | -172.41 | |||||
FCF Yield % | -95.85 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Modalis Therapeutics Corp Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil 円) | |||
EPS (TTM) (円) | -72.95 | ||
Beta | 1.07 | ||
Volatility % | 27.86 | ||
14-Day RSI | 47.73 | ||
14-Day ATR (円) | 2.293674 | ||
20-Day SMA (円) | 69.95 | ||
12-1 Month Momentum % | -75.7 | ||
52-Week Range (円) | 62 - 282 | ||
Shares Outstanding (Mil) | 34.19 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 1 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Modalis Therapeutics Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Modalis Therapeutics Corp Stock Events
Event | Date | Price(円) | ||
---|---|---|---|---|
No Event Data |
Modalis Therapeutics Corp Frequently Asked Questions
What is Modalis Therapeutics Corp(TSE:4883)'s stock price today?
The current price of TSE:4883 is 円70.00. The 52 week high of TSE:4883 is 円282.00 and 52 week low is 円62.00.
When is next earnings date of Modalis Therapeutics Corp(TSE:4883)?
The next earnings date of Modalis Therapeutics Corp(TSE:4883) is .
Does Modalis Therapeutics Corp(TSE:4883) pay dividends? If so, how much?
Modalis Therapeutics Corp(TSE:4883) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |